Pulmonx Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LUNG, updated each market day.
LUNG AI Sentiment
AI predicts Pulmonx Corporation Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Pulmonx Corporation Common Stock
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Sector
Exchange
Market Cap
$57,442,596
Cap Tier
Employees
296
Headquarters
REDWOOD CITY, CA
Listed Since
Oct. 1, 2020
Website
LUNG Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LUNG Volatility
Pulmonx Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
